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Background
We have previously shown that inflammatory agents
(LPS, IL-1β, β-amyloid peptides) that induce reactivity
and NOS-2 expression in glial cells down-regulate astro-
glial soluble guanylyl cyclase (sGC) in vitro and in vivo
[1,2].
Results
Here we show that the decrease in sGC activity and β1
subunit protein induced by LPS (10 ng/ml, 24 h) in cul-
tured rat cerebellar astrocytes is prevented by inhibitors of
proteasome activity (MG132 5 μM; lactacystin 10 μM)
whereas other protease inhibitors (calpain inhibitor 25
μM; ICE inhibitor II 100 μM and leupeptin 5 μM) were
not effective. Furthermore, immunocytochemistry and
confocal laser microscopy revealed that in LPS-treated
cells a strong sGC β1 immunorreactivity is evident in
aggregates in the cell nuclei where it co-localizes with 20S
proteasomes and ubiquitin in clastosomes, nucleoplas-
mic substructures involved in ubiquitin-proteasome-
dependent nuclear proteolysis, but do not colocalize with
others proteasome-enriched structures include promyelo-
cytic leukaemia bodies and splicing speckles. In contrast,
in untreated astrocytes clastosomes are scarce and sGC β1
immunorectivity shows a diffuse cytoplasmic pattern,
while in the nucleus it is very weak. A similar distribution
is observed when cells are treated with LPS and the protea-
some inhibitor MG132 or the protein synthesis inhibitor
cycloheximide.
Conclusion
LPS orchestrates the recruitment of sGC-β1 protein and
components of the ubiquitin-proteasome system to spe-
cialized nuclear bodies, clastosomes, suggesting a mecha-
nism for inflammation-induced down-regulation of sGC
in astrocytes.
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